Affiliate disclosure: This article contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you. This does not influence our assessment of the evidence below.
Evidence rating: Preliminary — the headline botanical has repeatedly failed its largest trials; the supporting ingredients are better supported than the star
What Prostadine Claims To Be
Prostadine is a liquid dropper formula marketed for prostate comfort and urinary flow in older men — the familiar cluster of getting up at night, weak stream, not quite finishing. Those symptoms are real and extremely common. What follows is an honest accounting of whether the plants in this bottle have been shown to help, and where the research says the opposite.
What’s Actually In It
Prostadine’s disclosed formula centres on marine botanicals plus a handful of standard prostate-supplement ingredients:
- Nori Yaki extract powder, Wakame extract, Kelp powder, Bladderwrack powder (all seaweeds; a natural iodine source)
- Saw palmetto (Serenoa repens)
- Pomegranate extract
- Shilajit
- Neem
- Plus nettle root extract, beta-sitosterol, zinc and vitamin D listed as supporting components
No per-ingredient quantities are published, and with a liquid dropper format that is a bigger gap than usual — dose per drop is not something you can eyeball.
What The Research Shows
According to PubMed, the evidence here splits sharply, and not in the direction the marketing implies.
Saw palmetto — the most famous ingredient here — has failed its best trials. A Cochrane systematic review pooling 32 randomized controlled trials in 5,666 men concluded that Serenoa repens was not superior to placebo for lower urinary tract symptoms. In the two high-quality long-term trials, the difference on the American Urological Association symptom score was 0.25 points — statistically and clinically nothing. Peak urine flow and prostate size were also unchanged. DOI
Even tripling the dose didn’t rescue it. The CAMUS trial, published in JAMA, randomized 369 men to escalating doses of saw palmetto extract — one, then two, then three times the standard 320 mg/day — over 72 weeks. Symptom scores improved in both groups, but placebo improved slightly more, and saw palmetto was no better on any secondary outcome. DOI
If saw palmetto is the reason you’re considering this product, the two most rigorous studies ever run on it say don’t.
There is one narrower positive finding. A 2024 randomized double-blind placebo-controlled trial in 66 healthy Japanese adults over 50 — people not diagnosed with BPH or overactive bladder but bothered by urinary frequency — found that 320 mg of saw palmetto extract daily for 12 weeks significantly reduced daytime urination frequency and the bother associated with it. That’s a different population from the Cochrane trials: symptomatic, but undiagnosed. DOI
Nettle root has the more consistent record of the two herbs. A 12-month randomized double-blind placebo-controlled multicentre study of 246 men found that 459 mg of stinging nettle root dry extract lowered the International Prostate Symptom Score significantly more than placebo (18.7 → 13.0 vs 18.5 → 13.8, p = 0.023), with fewer adverse events than placebo. The authors are careful to add that peak flow and residual urine volume did not differ meaningfully — so it appears to help how symptoms feel more than how the plumbing measures. DOI
A smaller 12-week randomized trial in 60 men found 450 mg/day of nettle root extract produced a moderate effect on IPSS and reduced markers of oxidative stress, with negligible change elsewhere. DOI
Beta-sitosterol — a supporting ingredient — outperforms the headliner. A systematic review of four double-blind randomized trials in 519 men found beta-sitosterol improved symptom scores by 4.9 IPSS points versus placebo and raised peak urinary flow by 3.91 mL/s. It did not shrink the prostate; trials were short and preparations non-standardised. DOI
Pomegranate’s evidence is in a different domain entirely. A randomized phase II trial of 104 men with rising PSA after treatment for localised prostate cancer found PSA doubling time lengthened from 11.9 to 18.5 months on pomegranate extract — but there was no placebo arm, and the authors called for placebo-controlled studies before drawing conclusions. That’s oncology follow-up research, not evidence about urinary symptoms. DOI
Shilajit, neem, and the seaweeds: no randomized human trials for prostate or urinary outcomes turned up in the PubMed searches run for this review. The seaweed blend does have one property worth flagging — it is a concentrated iodine source, and iodine intake is something people with thyroid conditions need to manage deliberately.
The Honest Verdict
What holds up: Nettle root and beta-sitosterol both have randomized placebo-controlled evidence for symptom-score improvement in men with prostate-related urinary complaints. Those are legitimate findings, and both ingredients are in this formula.
What doesn’t: Saw palmetto has been tested harder than almost any other supplement botanical and has not beaten placebo in the largest, longest, best-designed trials — including at triple dose. Its one positive trial was in men without a diagnosis. The pomegranate research is about PSA kinetics in cancer patients. Shilajit, neem and the marine ingredients have no located human trial support for this use.
Who this makes sense for: A man with mild, stable, already-evaluated urinary symptoms who wants to try a botanical adjunct, understands the effect will be modest at best, and is drawn primarily to the nettle-and-sitosterol side of the formula rather than the saw palmetto.
Who should skip it: Anyone with new, worsening, or unevaluated urinary symptoms — those need a doctor, because the differential includes things a supplement will not touch. Anyone with a thyroid condition, given the iodine load from four different seaweeds. And anyone buying primarily for the saw palmetto, since the strongest evidence available says it will not help.
Check current pricing and availability
View Prostadine on the official site
This article is for informational purposes only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Talk to your physician or urologist before starting any supplement, especially if you have a diagnosed condition or take medication.
Research cited via PubMed:
- Tacklind J, et al. Cochrane Database Syst Rev. 2012;12:CD001423. DOI
- Barry MJ, et al. JAMA. 2011;306(12):1344-51. DOI
- Kimura M, et al. Nutr Health. 2025;31(3):965-977. DOI
- Schneider T, Rübben H. Urologe A. 2004;43(3):302-6. DOI
- Karami AA, et al. Pak J Biol Sci. 2020;23(10):1338-1344. DOI
- Wilt TJ, et al. BJU Int. 1999;83(9):976-83. DOI
- Paller CJ, et al. Prostate Cancer Prostatic Dis. 2013;16(1):50-5. DOI